Advanced search
Publication Cover
Future Science OA Volume 9, 2023 - Issue 8
Submit an article Journal homepage
481
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Establishment of Cancer Cell Line Originating From a Patient With high-grade Serous Ovarian Carcinoma

Nguyen Thuy Linh1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam;2 Department of Pathology, Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam;3 Department of Pathology, Hanoi Medical University Hanoi, VietnamORCID Iconhttps://orcid.org/0000-0003-4326-1991
ORCID Icon,
Ngo Thu Hang1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam
,
Bui Khac Cuong1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam;4 Laboratory Animal Research Center, Vietnam Military Medical University, Hanoi, VietnamCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5781-5898
ORCID Icon,
Dang Thuy Linh1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam
,
Nham Thi Phuong Linh4 Laboratory Animal Research Center, Vietnam Military Medical University, Hanoi, Vietnam
,
Do Nguyen-Van5 Department of Pathophysiology & Immunology, Hanoi Medical University, Hanoi, Vietnam
,
Tran Ngoc Dzung2 Department of Pathology, Military Hospital 103, Vietnam Military Medical University, Hanoi, Vietnam
,
Can Van Mao1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam
,
Dang Thanh Chung2 Department of Pathology, Military Hospital 103, Vietnam Military Medical University, Hanoi, VietnamORCID Iconhttps://orcid.org/0000-0003-2376-1665
ORCID Icon,
Le Tri Chinh6 Department of Gynaecology Surgery, Vietnam National Cancer Hospital, Hanoi, Vietnam
,
Nguyen Phu Hung7 Faculty of Biotechnology, Thai Nguyen University of Sciences, Thai Nguyen, Vietnam
,
Hoang Van Tong1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam;8 Institute of Biomedicine & Pharmacy, Vietnam Military Medical University, Hanoi, VietnamORCID Iconhttps://orcid.org/0000-0002-7170-8810
ORCID Icon &
Nguyen Linh Toan1 Department of Pathophysiology, Vietnam Military Medical University, Hanoi, VietnamCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7850-3896
ORCID Icon show all
Article: FSO875 | Received 20 Feb 2023, Accepted 22 Jun 2023, Published online: 29 Jul 2023

References

  • SungH , FerlayJ , SiegelRLet al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
  • CheungA , ShahS , ParkerJet al.Non-Epithelial Ovarian Cancers: How Much Do We Really Know?Int. J. Environ. Res Public Health19(3), 1106 (2022).
  • TorreLA , TrabertB , DeSantisCEet al.Ovarian cancer statistics, 2018. CA Cancer J. Clin.68(4), 284–296 (2018).
  • CoburnS , BrayF , ShermanM , TrabertB. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int. J. Cancer140(11), 2451–2460 (2017).
  • MeiJ , TianH , HuangH-Set al.Cellular models of development of ovarian high-grade serous carcinoma: a review of cell of origin and mechanisms of carcinogenesis. Cell Prolif.54(5), e13029 (2021).
  • LeeKR , MutoMG. Chapter 25 - The Pathology of Pelvic-Ovarian Epithelial (Epithelial-Stromal) Tumors. In: Diagnostic Gynecologic and Obstetric Pathology (3rd Edition).HowittEdition BE, NucciMR, CrumCP, GranterSR, ParastMM, BoydTK ( Eds). Elsevier, PA, 865–948 (2018).
  • FranierBDL , ThompsonM. Early stage detection and screening of ovarian cancer: a research opportunity and significant challenge for biosensor technology. Biosens. Bioelectron.15(135), 71–81 (2019).
  • BoussiosS , RassyE , MoschettaMet al.BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside. Cancers (Basel)14(16), 3888 (2022).
  • StewartC , RalyeaC , LockwoodS. Ovarian Cancer: An Integrated Review. Semin. Oncol. Nurs.35(2), 151–156 (2019).
  • ArmstrongDK. Relapsed ovarian cancer: challenges and management strategies for a chronic disease. The Oncologist7(Suppl. 5), 20–28 (2002).
  • SueblinvongT , GhebreR , IizukaYet al.Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors. PLOS ONE7(11), e50519 (2012).
  • YamadaT , HattoriK , SatomiH , OkazakiT , MoriH , HiroseY. Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary. J. Ovarian Res.9(1), 32 (2016).
  • YamadaT , KandaT , MoriH , ShimokawaK , KagawaM , ShibayamaY. Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary. J. Ovarian Res.6(1), 8 (2013).
  • YamadaT , UedaM , OtsukiY , UekiM , SugimotoO. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol. Oncol.40(2), 118–128 (1991).
  • OuelletV , ZietarskaM , PortelanceLet al.Characterization of three new serous epithelial ovarian cancer cell lines. BMC cancer8, 152 (2008).
  • PanZ , HooleyJ , SmithDH , YoungP , RobertsPE , MatherJP. Establishment of human ovarian serous carcinomas cell lines in serum free media. Methods56(2012), 432–439 (2012).
  • SilvaF , CoelhoF , PeixotoAet al.Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line – IPO43. Cancer Cell International27(1), 175 (2022).
  • HamiltonTC , YoungRC , McKoyWMet al.Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res.43(11), 5379–5389 (1983).
  • PejovicT , HeimS , MandahlNet al.Chromosome Aberrations in 35 Primary Ovarian Carcinomas. Genes, Chromosomes & Cancer4, 58–68 (1992).
  • KobelM , RonnettBM , SinghN , SoslowRA , GilksCB , McCluggageWG. Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility. Int. J. Gynecol. Pathol.38(Suppl. 1), S123–S131 (2019).
  • DomckeS , SinhaR , LevineDA , SanderC , SchultzN. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun.4, 2126 (2013).
  • SurowiakP , MaternaV , MaciejczykAet al.CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients. Anticancer Res.26(6C), 4943–4948 (2006).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.